Drug intelligence / Profile preview

zirconium-89-labeled RO5479599

Development stage
Unknown
Lead developer
Roche
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Monoclonal Antibodies → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

Zirconium-89-labeled RO5479599 is a radiolabeled monoclonal antibody designed for immunoPET imaging. The antibody targets HER3 (human epidermal growth factor receptor 3), which is overexpressed in various solid tumors. By labeling the antibody with the positron-emitting radioisotope zirconium-89, this agent enables non-invasive visualization and quantification of HER3 expression in tumors using PET imaging. This approach supports patient selection and monitoring of therapeutic response in clinical trials involving anti-HER3 therapies. The primary indication studied has been metastatic and/or locally advanced malignant HER3-positive solid tumors of epithelial cell origin[2][9].

Other names
zirconium-89-labeled RO5479599zirconium89-labeled RO5479599zirconium 89-labeled RO547959989Zr-RO5479599
02

Targets

ERBB3 (Erb-b2 receptor tyrosine kinase 3)

Beyond the preview

Go deeper on zirconium-89-labeled RO5479599.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on zirconium-89-labeled RO5479599.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call